Overall, 61.5% of patients were oestrogen-receptor-positive at the time of breast cancer diagnosis (1406/2287—19 studies) and 51.5% were progesterone-receptor-positive (1050/2037—15 studies). Here, PGR is linked to breast carcinoma.